241 related articles for article (PubMed ID: 34399001)
21. Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination.
Kreuter A; Licciardi-Fernandez MJ; Burmann SN; Burkert B; Oellig F; Michalowitz AL
Clin Exp Dermatol; 2022 Jan; 47(1):161-163. PubMed ID: 34291477
[TBL] [Abstract][Full Text] [Related]
22. Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine.
Di Bona D; Miniello A; Nettis E
Clin Mol Allergy; 2022 Dec; 20(1):13. PubMed ID: 36503530
[TBL] [Abstract][Full Text] [Related]
23. Rare case of itraconazole induced SDRIFE (symmetrical drug-related intertriginous and flexural exanthema).
Koschitzki K; Karrer S; Berneburg M; Niebel D; Drexler K
J Dtsch Dermatol Ges; 2024 Jun; 22(6):833-836. PubMed ID: 38567643
[No Abstract] [Full Text] [Related]
24. Symmetrical drug-related intertriginous and flexural exanthema due to ranitidine.
Binitha MP; Sasidharanpillai S; John R; Sherjeena PV
Indian J Pharmacol; 2014; 46(5):551-2. PubMed ID: 25298589
[TBL] [Abstract][Full Text] [Related]
25. Zoledronic acid-associated symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): report of baboon syndrome in a woman with recurrent metastatic breast cancer after receiving zoledronic acid.
Cohen PR
Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437156
[TBL] [Abstract][Full Text] [Related]
26. Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19).
Ben Salem C; Khelif A; Sahnoun D; Ghariani N; Sriha B; Denguezli M
J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e516-e517. PubMed ID: 35274363
[No Abstract] [Full Text] [Related]
27. Symmetrical drug-related intertriginous and flexural exanthema-like rash related to severe acute respiratory syndrome coronavirus 2 infection.
Escolà H; March-Rodriguez A; Pujol RM
Indian J Dermatol Venereol Leprol; 2023; 89(1):119-121. PubMed ID: 36331827
[No Abstract] [Full Text] [Related]
28. First case of symmetric drug-related intertriginous and flexural exanthema (sdrife) due to rivastigmine?
Allain-Veyrac G; Lebreton A; Collonnier C; Jolliet P
Am J Clin Dermatol; 2011 Jun; 12(3):210-3. PubMed ID: 21469764
[TBL] [Abstract][Full Text] [Related]
29. Paracetamol-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient receiving apremilast therapy.
Megna M; Cinelli E; Napolitano M; Fabbrocini G; Patruno C
Contact Dermatitis; 2019 Dec; 81(6):451-454. PubMed ID: 31328275
[No Abstract] [Full Text] [Related]
30. A case of fixed drug eruption induced by doxycycline, mimicking a symmetrical drug-related intertriginous and flexural exanthema (SDRIFE).
Favrelière S; Hosteing S; Jazeron JF; Allouchery M; Lafay-Chebassier C; Perault-Pochat MC
Therapie; 2020; 75(5):511-513. PubMed ID: 31761151
[No Abstract] [Full Text] [Related]
31. Baboon syndrome and toxic erythema of chemotherapy: Fold (intertriginous) dermatoses.
Wolf R; Tüzün Y
Clin Dermatol; 2015; 33(4):462-5. PubMed ID: 26051062
[TBL] [Abstract][Full Text] [Related]
32. Remdesivir-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE)? A case report with review of the literature.
Heck J; Stichtenoth DO; Mettin R; Jöckel J; Bickel C; Krichevsky B
Eur J Clin Pharmacol; 2021 Jan; 77(1):141-144. PubMed ID: 32761371
[No Abstract] [Full Text] [Related]
33. Unique Case of Urticarial Skin Eruptions After COVID-19 Vaccination.
Baraldi C; Boling LB; Patrizi A; Prodi C; Deleonardi G; Gaspari V; Misciali C
Am J Dermatopathol; 2022 Mar; 44(3):198-200. PubMed ID: 34291744
[No Abstract] [Full Text] [Related]
34. Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford-AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?
Ungari M; Pezzarossa E
Am J Dermatopathol; 2022 Jan; 44(1):80-82. PubMed ID: 34726187
[No Abstract] [Full Text] [Related]
35. Symmetrical drug-related intertriginous and flexural exanthema: a rare and unusual drug eruption.
Lyons D; Barry R; Ni Raghallaigh S
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38199652
[No Abstract] [Full Text] [Related]
36. Symmetrical drug-related intertriginous and flexural exanthema due to codeine.
Erfan G; Yanik ME; Kaya S; Tasolar K; Oznur M; Kulac M
Indian J Dermatol Venereol Leprol; 2015; 81(4):405-6. PubMed ID: 26087105
[No Abstract] [Full Text] [Related]
37. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome?
Häusermann P; Harr T; Bircher AJ
Contact Dermatitis; 2004; 51(5-6):297-310. PubMed ID: 15606657
[TBL] [Abstract][Full Text] [Related]
38. Symmetrical drug-related intertriginous and flexural exanthema induced by metronidazole suppository.
Zhang H; Xie Z
Contact Dermatitis; 2021 Jun; 84(6):486-488. PubMed ID: 33421140
[No Abstract] [Full Text] [Related]
39. Clozapine-induced symmetrical drug-related intertriginous and flexural exanthema: first reported cases.
Rao A; Francis N; Morar N
Br J Dermatol; 2012 May; 166(5):1142-3. PubMed ID: 22121994
[No Abstract] [Full Text] [Related]
40. Phenotypic spectrum of serious cutaneous-only adverse event following immunization with COVID-19 vaccines: a multicentre case series and literature review.
Balogun M; Millette D; Yip V; Chan SA; Lee P; Gamal N; Hashim N; Phillips D; Walsh M; Trehan P; Hanna-Bashara L; Abdullah A; Wernham A; Tso S
Clin Exp Dermatol; 2022 Mar; 47(3):614-616. PubMed ID: 34748655
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
